DK2022788T3 - Nyt krystal af 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propansyre - Google Patents

Nyt krystal af 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propansyre

Info

Publication number
DK2022788T3
DK2022788T3 DK07744104.6T DK07744104T DK2022788T3 DK 2022788 T3 DK2022788 T3 DK 2022788T3 DK 07744104 T DK07744104 T DK 07744104T DK 2022788 T3 DK2022788 T3 DK 2022788T3
Authority
DK
Denmark
Prior art keywords
benzisoxazol
hydroxybenzoyl
cyclopentyloxy
methoxy
hydroxy
Prior art date
Application number
DK07744104.6T
Other languages
English (en)
Inventor
Kenji Yonezawa
Hironori Kotsubo
Yasutaka Baba
Yukie Tada
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK2022788T3 publication Critical patent/DK2022788T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK07744104.6T 2006-05-26 2007-05-25 Nyt krystal af 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propansyre DK2022788T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006146220 2006-05-26
PCT/JP2007/060670 WO2007138996A1 (ja) 2006-05-26 2007-05-25 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸の新規な結晶

Publications (1)

Publication Number Publication Date
DK2022788T3 true DK2022788T3 (da) 2010-12-13

Family

ID=38778516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07744104.6T DK2022788T3 (da) 2006-05-26 2007-05-25 Nyt krystal af 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propansyre

Country Status (27)

Country Link
US (1) US7977492B2 (da)
EP (1) EP2022788B1 (da)
JP (1) JP5117381B2 (da)
KR (1) KR101389038B1 (da)
CN (1) CN101454298B (da)
AT (1) ATE479666T1 (da)
AU (1) AU2007268771B2 (da)
BR (1) BRPI0712909A2 (da)
CA (1) CA2652939C (da)
CY (1) CY1111398T1 (da)
DE (1) DE602007008882D1 (da)
DK (1) DK2022788T3 (da)
EC (1) ECSP089000A (da)
ES (1) ES2351065T3 (da)
HR (1) HRP20100544T1 (da)
IL (1) IL195416A (da)
MA (1) MA30510B1 (da)
MX (1) MX2008014906A (da)
NO (1) NO20084632L (da)
NZ (1) NZ573034A (da)
PL (1) PL2022788T3 (da)
PT (1) PT2022788E (da)
RS (1) RS51517B (da)
RU (1) RU2429233C2 (da)
SI (1) SI2022788T1 (da)
WO (1) WO2007138996A1 (da)
ZA (1) ZA200809922B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2562170T3 (pl) * 2006-02-21 2015-03-31 Toyama Chemical Co Ltd Sposób wytwarzania estru kwasu 3-{5-[4-(cyklopentyloksy)- 2-hydroksybenzoilo]-2-[(3-okso-2-podstawionego-2,3-dihydro-1,2-benzizoksazol-6-ilo)metoksy]fenylo}- propionowego i związku pośredniego dla sposobu
NZ588128A (en) * 2008-03-27 2012-12-21 Toyama Chemical Co Ltd USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF alpha INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
CN102014889A (zh) 2008-04-22 2011-04-13 富山化学工业株式会社 组合使用二苯甲酮衍生物或其盐和免疫抑制剂的方法以及包含这些组分的药物组合物
CN103183647B (zh) * 2011-12-28 2017-06-09 天津市国际生物医药联合研究院有限公司 3‑{[2‑[3‑氧‑(1,2‑苯并异噻唑‑6‑基)甲氧基‑5‑(2‑羟基‑4‑环戊氧基苯甲酰基)]苯基}丙酸的制备方法
CN118255728B (zh) * 2024-01-25 2024-07-30 中国医学科学院阜外医院 化合物的盐型晶型用于治疗射血分数保留的心衰的用途
CN118252824B (zh) * 2024-01-25 2024-09-17 中国医学科学院阜外医院 化合物用于治疗射血分数保留的心衰的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042150A (en) 1960-01-26 1962-07-03 Lukawsky Michael Emergency brake and anti-skid device
WO1995001964A1 (fr) * 1993-07-06 1995-01-19 Yamanouchi Pharmaceutical Co., Ltd. Nouveau cristal de derive de benzodiazepine
AU769778B2 (en) * 1998-11-05 2004-02-05 Toyama Chemical Co. Ltd. Novel compounds and pharmaceutical use thereof
JP4976617B2 (ja) * 2000-03-17 2012-07-18 富山化学工業株式会社 新規なベンゾフェノン誘導体およびその塩
JP4554926B2 (ja) 2001-11-16 2010-09-29 富山化学工業株式会社 新規なベンゾフェノン誘導体またはその塩

Also Published As

Publication number Publication date
BRPI0712909A2 (pt) 2012-10-02
KR101389038B1 (ko) 2014-04-28
US7977492B2 (en) 2011-07-12
RS51517B (en) 2011-06-30
IL195416A (en) 2012-07-31
DE602007008882D1 (de) 2010-10-14
ES2351065T3 (es) 2011-01-31
MX2008014906A (es) 2008-12-09
ECSP089000A (es) 2009-02-27
KR20090014194A (ko) 2009-02-06
HRP20100544T1 (hr) 2010-11-30
AU2007268771B2 (en) 2011-12-01
ATE479666T1 (de) 2010-09-15
EP2022788A1 (en) 2009-02-11
SI2022788T1 (sl) 2011-01-31
RU2429233C2 (ru) 2011-09-20
EP2022788B1 (en) 2010-09-01
IL195416A0 (en) 2009-08-03
WO2007138996A1 (ja) 2007-12-06
PL2022788T3 (pl) 2011-03-31
CN101454298B (zh) 2011-11-16
CY1111398T1 (el) 2015-08-05
ZA200809922B (en) 2010-02-24
JPWO2007138996A1 (ja) 2009-10-08
EP2022788A4 (en) 2009-06-24
CA2652939C (en) 2014-12-02
AU2007268771A1 (en) 2007-12-06
US20090275757A1 (en) 2009-11-05
NO20084632L (no) 2008-12-12
JP5117381B2 (ja) 2013-01-16
CA2652939A1 (en) 2007-12-06
CN101454298A (zh) 2009-06-10
PT2022788E (pt) 2010-10-04
MA30510B1 (fr) 2009-06-01
RU2008151778A (ru) 2010-07-10
NZ573034A (en) 2010-08-27

Similar Documents

Publication Publication Date Title
DK2022788T3 (da) Nyt krystal af 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propansyre
AR117778A2 (es) Forma sólida de un naftaleno carboxamida
WO2011123845A3 (en) A computing device interface
RS54445B1 (en) 3,5-DIAMINO-6-CHLORO-N- (N- (4- (4- (2- (HEXYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) ETHOXY) PHENYL) BUTYL) CARBAMIMIDOIL) PYRAZINE -2-CARBOXAMIDE
MX2014000556A (es) Compuesto heterociclico fusionado y su uso para el control de plagas.
BR112014013872A2 (pt) amidas dos ácidos n-(1,2,5-oxadiazol-3-il) -, n-(1,3,4-oxadiazol-2-il)-, n-(tetrazol - 5 - il) - e n - (triazol -5-il) - aril-carboxílico e sua utilização enquanto herbicidas
EA200702541A1 (ru) Полиморфы этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты
WO2007109080A3 (en) Deuterated hepatitis c protease inhibitors
DE602005022083D1 (de) Methansulfonatsalze von abirateron-3-estern und wiederherstellung von salzen von abirateron-3-estern durch auflösung in methyl-tert-butyl-ether
ATE383074T1 (de) Herbizidzusammensetzung
EA200600381A1 (ru) Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и его применение в качестве лекарственного средства
TW200736195A (en) Methods for preparing sulfonamide substituted alcohols and intermediates thereof
RS52881B (en) BENZAMIDINE COMPOUNDS USED AS HISTONAL DEACETYLASE INHIBITORS
DK1874762T3 (da) Fremgangsmåde til fremstilling af 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamid
WO2008047951A3 (en) An alzheimer' s disease progression inhibitor containing heterocyclic compound
BRPI0507248A (pt) compostos do tipo hidrazina e sua utilização em composições farmacêuticas para o tratamento de doença cardiovasculares
FR2884354B3 (fr) Structure de logement pour batterie d'ordinateur portable
ECSP11011286A (es) Formulaciones orales sólidas de una pirido-pirimidinona
BRPI0814989A2 (pt) Triazolilpiridina cetonas herbicidas.
FR2979567B1 (fr) Machine-outil portative ayant un dispositif d'appui, notamment defonceuse
UA91602C2 (ru) Пиридазиноновое производное, его применение в качестве гербицида и промежуточное соединение
DK1906938T3 (da) Farmaceutisk formulering af nitrooxyderivater af NSAID'er
EA201001270A1 (ru) Новый способ получения сульфонилпирролов в качестве ингибиторов гистондезацетилаз (hdac)
Zhao et al. Piezoelectric-type stepping precision rotary actuator
FR2914982B1 (fr) Dispositif d'eclairage portable a accrochage ameliore